Thomas Frinzi on investment
From STAAR Surgical CEO, Tom Frinzi Discusses Exciting Growth and Developments for 2023 · · EYE NEWS MEDIA
“Here closer to home in the U.S we've made a real conscious decision to invest in people and programs. We've added new practice development people, clinical applications people, territory managers and most recently added really high-end executives to continue to raise the bar in terms of the quality of our team.”
On , Thomas Frinzi, Advisor at STAAR SURGICAL CO, spoke about investment during STAAR Surgical CEO, Tom Frinzi Discusses Exciting Growth and Developments for 2023 on EYE NEWS MEDIA.
About Thomas Frinzi
In a September 2023 interview, Thomas Frinzi, Chair of the Board, President and CEO of STAAR Surgical, discussed the company's recent performance and developments. He stated that the company had a strong first quarter with 20 percent growth globally, noting that China, a major market, had recovered from a dip in late 2022, and that the U.S. market grew by 78 percent year over year. Frinzi said the company had invested in its U.S. team by adding practice development personnel, clinical applications staff, territory managers, and new executives, which he described as raising the quality of the team. Frinzi attributed increased adoption of the EVO ICL lens to expanded digital marketing and direct-to-consumer advertising, as well as the procedure's simplification due to the elimination of the peripheral iridotomy. He cited 99.4 percent patient satisfaction and two million implants worldwide, adding that no ophthalmologist had expressed dissatisfaction with the lens's quality of vision. Frinzi described the current period as an exciting time to be associated with STAAR Surgical.